Gonadorelin vs Kisspeptin vs HCG: Three Levels of the Same Hormone Axis

The short answer

The HPG axis is a relay. Kisspeptin signals hypothalamic neurons to release GnRH. GnRH acts on the pituitary to release LH and FSH. LH acts on the gonads. Kisspeptin-10 enters this relay at the top, gonadorelin - which is synthetic GnRH - enters at the middle, and HCG acts at the bottom, directly on the LH receptor in the gonad.

Kisspeptin-10: the top of the chain

Kisspeptins are a family of peptides from the KISS1 gene that act on the KISS1R receptor, also called GPR54, on GnRH neurons. Kisspeptin-10 is the shortest active form, the final 10 amino acids of the longer precursor, and it retains activity at the receptor. Because it acts at the top of the axis, any effect it produces depends on the pituitary and gonad below it responding normally.

Gonadorelin: the middle link

Gonadorelin has the same 10-amino-acid sequence as natural GnRH. It acts on GnRH receptors in the pituitary, prompting LH and FSH release. Its research literature makes one point repeatedly: the pattern of exposure matters. Pulsatile delivery mimics the natural rhythm, while continuous exposure to GnRH or its analogs desensitises the receptor. Published work therefore uses infusion pumps when studying pulsatile designs.

HCG: acting directly on the gonad

HCG is a large glycoprotein hormone made of two subunits, structurally close to LH. It binds the shared LH/HCG receptor directly, so it does not need the hypothalamus or pituitary to act. Its published in-vitro literature centres on Leydig cells, where it is used as a standard stimulus for studying steroid-producing cell function.

Why position matters for research design

Because the three act at different levels, they answer different questions. A compound acting higher in the axis tests whether the downstream links respond; a compound acting at the gonad bypasses them. That is why the literature presents them as tools for different parts of one system rather than as substitutes for each other.